Diacor News and Opinion

Y.K. Almoayyed & Sons BSC(c) will begin representing Diacor solutions for radiation therapy in the Kingdom of Bahrain.  We excited about this new partnership and working with the Bio-Medical Division of Y.K. Almoayyed and Sons.  Our Centralite Patient Alignment Lasers, MammoRx Immobilization Systems, Zephyr Patient Transport System, and our CT Overlays will all be available through this new partnership. 

Diacor is pleased to announce that Al Haddad Medical became Diacor's newest global distributor.  Based in Jeddah, Saudia Arabia, Al Haddad Medical will represent Diacor's Centralite Patient Alignment Lasers, MammoRx Breast Immobilization Systems, Zephyr Patient Transport System, and CT Overlays.  Diacor looks forward to working with Dr. Reda Al Haddad and his team in the weeks and months ahead.

ASTRO released a press release yesterday, noting a study in the June 1st issue of the International Journal of Radiation Oncology*Biology*Physics, that breast cancer patients can reduce their risk of recurrence by almost 30% and increase their five-year overall survival by almost 50% with use of Postmastectomy radiation therapy (PMRT).  Click here to view the full press release.

DEGRO opened this past Thursday, June 3, 2010, with an opening reception and the first chance to view the new Zephyr Patient Transport System from Diacor at a major European trade show for radiation therapy.  Mike Koger, Product Specialist for the Zephyr, traveled to Magdeburg, Germany to support Diacor's exclusive distributor for Germany, Austria, and Switzerland - HEK Medical.  After the first full day of DEGRO, it sounds like the Zephyr has been a hit with conference attendees. 

In addition to the Zephyr, HEK Medical has product information on all of Diacor's other product families - Centralite and Centralite CT Patient Alignment Lasers, MammoRx Breast Immobilization Systems, Integra Head and Neck Immobilization, and CT Overlays for CT SIM. 

Here's a few images from Germany....

Members of the American Society for Radiation Oncology (ASTRO) created a new web site last fall for helping cancer patients and their families understand the available radiotherapy treatment options.  The site includes treatment information, statistics, dictionary of radiation therapy terms, as well as quick links for discovering additional detail.  For example, the site notes that nearly 1.5 million Americans will learn they have cancer this year and that 2/3rds of all cancer is treated with radiation. 

The site is called RTAnswers.org and looks to be a great resource for the radiation therapy community.

Researchers at the Henry Ford Hospital in Detroit, Michigan, will present a poster at this year's American Society of Clinical Oncology (ASCO) Annual Meeting noting that from their observations, breast and prostate cancer patients who regularly exercise during and after cancer treatment report having a better quality of life and being less fatigued.  According to Dr. Walker, Division Director of Breast Services in the Department of Radiation Oncology, "using exercise as an approach to cancer care has the potential to benefit patients both physically and psychologically, as well as mitigate treatment side effects." 

The abstract of the study is available online at http://www.ASCO.org.

In a recent article published online in CANCER, a peer-reviewed journal of the American Cancer Society, Dr. Stephan Gripp, MD, of the University Hospital Duesseldorf in Germany and colleagues evaluated the treatment of patients who were referred for palliative radiotherapy.  Their analysis found that a considerable proportion of patients with end-stage or terminal cancer do not benefit from palliative radiation therapy despite spending most of their remaining life undergoing treatments. 

To view the full press release from the American Cancer Society, please click here.

Euro Meditech Co Ltd., Diacor's exclusive representative for the Japanese radiotherapy market, attended this year's Japanese Brachytherapy Society Meeting on May 15th and 16th, 2010.  Euro Meditech displayed marketing collateral for the Zephyr Patient Transport System for HDR Brachytherapy, as well as other devices that Euro Meditech distributes.  Click here to view Euro Meditech's web page on the Zephyr Patient Transport System to find out all of the latest information.

In partnership with our German, Austria, and Switzerland distributor, HEK Medical GmbH will have on display at this year's DEGRO the Zephyr Patient Transport System.  The Zephyr is designed to ease patient transfer of HDR patients while at the same time minimize movement of applicator or needles in relationship to the implanted area.

This year's DEGRO will be held in Magdeburg, Germany.  HEK Medical's booth number is F01.  Please stop by and visit with us!

Diacor is excited to announce that IberVoxel, Lda., located in Parede, is our newest global distributor.  IberVoxel will offer the following Diacor products to the radiotherapy centers in Portugal:

• Centralite Red and Green Fixed Lasers
• Centralite CT Moving Lasers
• MammoRx Patient Positioning System
• Carbon Fiber CT Overlays
• Zephyr Patient Transport System for HDR Brachytherapy

If you are interested in speaking with IberVoxel about Diacor products, please visit their web site by clicking here.

IberVoxel's contact information can also be found on the distributor page of Diacor's web site.